作者: 創(chuàng)新 時(shí)間: 2025-3-21 22:11
Orla Hardiman,Colin P. Doherty,Peter BedeProvides a clear overview of the process of neurodegeneration and an updated synthesis of ideas in these disorders.Presents succinct clinical information in a standardized format for easy access.Compr作者: 斷斷續(xù)續(xù) 時(shí)間: 2025-3-22 02:31 作者: 樣式 時(shí)間: 2025-3-22 07:24
HIV and Other Infectious Causes of Dementia,epatitis C. Their clinical presentations, neuropsychological profiles, imaging findings and CSF findings are discussed..Many of these organisms cause cognitive impairment or dementia through inflammatory and degenerative pathways common to many neurodegenerative disorders.作者: 改變立場(chǎng) 時(shí)間: 2025-3-22 10:14 作者: 尊重 時(shí)間: 2025-3-22 15:53
https://doi.org/10.1007/978-3-319-23309-3Alzheimer; Neurodegeneration; Neurodegenerative disease; Parkinson; Vascular Dementia; amyotrophic latera作者: 反話 時(shí)間: 2025-3-22 20:05 作者: 前面 時(shí)間: 2025-3-22 22:19
Imaging Biomarkers in Neurodegenerative Conditions,ovel quantitative imaging techniques are increasingly utilized as diagnostic, prognostic and monitoring biomarkers. With the advent of novel MRI techniques, it is now possible to capture subtle structural and metabolic changes in vivo and comprehensively characterize specific disease phenotypes and 作者: PAGAN 時(shí)間: 2025-3-23 02:09
Role of Neuropsychology in Neurodegeneration,re increasingly viewed as an integral part of the work-up of these patients. This chapter summarises the different aspects of the neuropsychological assessment and the basic knowledge required on the part of the referring clinician. We briefly discuss the cognitive domains commonly examined during a作者: 搖擺 時(shí)間: 2025-3-23 06:00 作者: 杠桿 時(shí)間: 2025-3-23 10:28
Dementia and Cerebrovascular Disease,es a number of different conditions including cortical vascular dementia, subcortical ischemic dementia, strategic-infarct dementia, hypoperfusion dementia, haemorrhagic dementia and dementias resulting from specific arteriopathies such as CADASIL. Diagnosis requires the presence of cognitive declin作者: Affirm 時(shí)間: 2025-3-23 14:02 作者: 痛苦一生 時(shí)間: 2025-3-23 19:06 作者: Infiltrate 時(shí)間: 2025-3-24 01:44 作者: 一大塊 時(shí)間: 2025-3-24 04:41 作者: infatuation 時(shí)間: 2025-3-24 08:15
Parkinsonism-Plus Syndromes,ially mimic idiopathic Parkinson’s Disease (IPD). They are however a diverse group of proteinopathies and their diagnosis is important, both in terms of management and prognosis. There are general “red flags” that may herald the diagnosis, including atypical rapid progression, poor response to domam作者: notification 時(shí)間: 2025-3-24 13:18 作者: deciduous 時(shí)間: 2025-3-24 17:16 作者: 小故事 時(shí)間: 2025-3-24 21:12
Managing Neuropsychiatric Symptoms of Neurodegenerative Diseases,ion of these symptoms represents a complex interplay between anatomic, physiologic, and psychosocial factors. Despite an expanding evidence-base, management of neuropsychiatric symptoms in neurologic disease remains challenging. This chapter explores the neurobiology of the common neuropsychiatric s作者: Prophylaxis 時(shí)間: 2025-3-25 00:51
HIV and Other Infectious Causes of Dementia,epatitis C. Their clinical presentations, neuropsychological profiles, imaging findings and CSF findings are discussed..Many of these organisms cause cognitive impairment or dementia through inflammatory and degenerative pathways common to many neurodegenerative disorders.作者: Leaven 時(shí)間: 2025-3-25 05:33
Neuroinflammatory Disorders,enetic and environmental factors predispose to its development. The pathological hallmark of disease is focal demyelination that affects both the cortical grey matter and the white matter tracts in the brain and spinal cord, characterised by perivascular infiltration of activated macrophages and T l作者: 新義 時(shí)間: 2025-3-25 08:28 作者: Decongestant 時(shí)間: 2025-3-25 11:44
Palliative Care and End of Life Care,of quality of life for both patients and carers. Palliative care enhances quality of life for patients and family members by addressing medical symptoms and individual psychological, social, and spiritual needs. Emphasis is placed on patient autonomy and dignity. Patients are encouraged to generate 作者: PALSY 時(shí)間: 2025-3-25 16:05
tion from random signals. Second order statistics like autocorrelation function and probability density function are used only for linear signals such as Gaussian noise. Nonlinear signal processing can be applied to pattern recognition and communication. Some examples of nonlinear signals are music,作者: 逗它小傻瓜 時(shí)間: 2025-3-25 23:05 作者: 過(guò)濾 時(shí)間: 2025-3-26 03:46 作者: sterilization 時(shí)間: 2025-3-26 07:37 作者: 繁榮中國(guó) 時(shí)間: 2025-3-26 10:05 作者: 正式演說(shuō) 時(shí)間: 2025-3-26 13:41 作者: 摻和 時(shí)間: 2025-3-26 17:49 作者: 摘要 時(shí)間: 2025-3-27 00:51 作者: 認(rèn)識(shí) 時(shí)間: 2025-3-27 01:12
Orla Hardiman,Matthew C. Kiernan,Leonard H. van den Berguced where it is shown that scanning in a restricted angular range results in missing information, which in term causes the problem to become underdetermined. The use of generally available a priori information can compensate for the missing information and therefore improve the reconstructed image.作者: commune 時(shí)間: 2025-3-27 09:12 作者: languid 時(shí)間: 2025-3-27 09:44
Seán O’Dowd,Daniel Healy,David Bradleyshown in this chapter that the Hankel norm provides a meaningful measurement for functions which are essentially bounded on the unit circle |.|= 1. However, since the Hankel norm of any function is zero, in contrast to the .. norms on |.| = 1, it is only a “semi-norm” in the sense that any two funct作者: CRUDE 時(shí)間: 2025-3-27 15:24
Lewis P. Rowland,Peter Bede,Marwa Elamin,Orla Hardimanevel computer vision. .Computer vision has progressed considerably over recent years. Frommethods only applicable to simple images, it has developed to dealwith increasingly complex scenes, volumes and time sequences. Asubstantial part of this book deals with the problem of designingmodels that can 作者: aneurysm 時(shí)間: 2025-3-27 18:41 作者: hauteur 時(shí)間: 2025-3-28 01:45 作者: 滋養(yǎng) 時(shí)間: 2025-3-28 02:32
,Alzheimer’s Disease,anding the pathogenesis. It is hoped that the next generation of therapeutic interventions will act upon the underlying mechanisms and truly modify the onset and progression of this prevalent disease.作者: ANNUL 時(shí)間: 2025-3-28 06:54
Book 2016Latest editiond outcomes of the conditions most frequently encountered in clinical practice..Beginning with an overview of the general principles that underlie degeneration, and the contribution of established and new diagnostics techniques, the book goes on to describe the most common neurodegenerative condition作者: 單調(diào)性 時(shí)間: 2025-3-28 11:35 作者: Foreshadow 時(shí)間: 2025-3-28 15:07
Parkinsonism-Plus Syndromes,es of the four main Parkinsonism-Plus disorders: Multiple Systems Atrophy [MSA], Progressive Supranuclear Palsy [PSP], Corticobasal Degeneration [CBD] and Dementia with Lewy Bodies [DLB]. The diagnosis remains clinical and vigilant neurological monitoring along with a strong multidisciplinary team support are the cornerstone of management.作者: 假 時(shí)間: 2025-3-28 22:50
Palliative Care and End of Life Care,l be 2–3 years but 25 % will be alive at 5 years and 10 % at 10 years whereas multiple sclerosis (MS) will have a much longer prognosis which may be over 20 years. However, at some time during the disease progression palliative care may be appropriate.作者: 強(qiáng)有力 時(shí)間: 2025-3-29 01:06 作者: 錫箔紙 時(shí)間: 2025-3-29 03:46 作者: incarcerate 時(shí)間: 2025-3-29 11:01
Fronto-Temporal Dementia (FTD),chnology. We outline current treatment options and discuss potential future therapies currently under investigation in the context of our rapidly increasing understanding of underlying disease patho-mechanisms in this disorder.作者: Tempor 時(shí)間: 2025-3-29 13:11
,Huntington’s Disease,o slow the pace of neurodegeneration, which generally has a 20-year course after initial diagnosis. The clinical manifestations of the disease vary widely but they generally include dysfunction in cognition, mood, voluntary motor control and most patients have the signature finding of chorea.作者: consent 時(shí)間: 2025-3-29 17:48 作者: 地名表 時(shí)間: 2025-3-29 23:00 作者: arboretum 時(shí)間: 2025-3-30 02:49 作者: Terminal 時(shí)間: 2025-3-30 06:44
Managing Neuropsychiatric Symptoms of Neurodegenerative Diseases,gement of neuropsychiatric symptoms in neurologic disease remains challenging. This chapter explores the neurobiology of the common neuropsychiatric symptoms encountered in clinical practice, and outlines current approaches toward their pharmacological and behavioral management.作者: MARS 時(shí)間: 2025-3-30 10:34 作者: FIS 時(shí)間: 2025-3-30 15:29 作者: Projection 時(shí)間: 2025-3-30 16:52
David Oliver,Sinead Maguire,Orla Hardiman,Peter Bede作者: 聽(tīng)覺(jué) 時(shí)間: 2025-3-30 22:36 作者: 細(xì)胞 時(shí)間: 2025-3-31 01:27
Dementia and Cerebrovascular Disease, from dementia onset to death is 3.9 years for patients with VaD, as compared with 7.1 years for patients with AD. There are currently no established biochemical markers for VaD; and currently MR changes of ischaemia are the most widely used biomarker. Modifiable risk factors for VaD are those that 作者: 修飾 時(shí)間: 2025-3-31 08:57 作者: Ballad 時(shí)間: 2025-3-31 09:45
Neuroinflammatory Disorders,, disease progression, and MS subtypes are being developed..As the disease progressses the majority of MS patients develop irreversible disability due to axonal loss. To date no DMT has been proven to alter the course of the progressive phase of the disease. However, recent advances in glial biology作者: 混沌 時(shí)間: 2025-3-31 17:03 作者: Lamina 時(shí)間: 2025-3-31 20:01
